Advertisement

Topics

Chicago Prostate Cancer Center Company Profile

00:08 EST 19th November 2017 | BioPortfolio


News Articles [4197 Associated News Articles listed on BioPortfolio]

Proton therapy for prostate cancer is advantageous to imrt according to new study

(Northwestern Memorial HealthCare) Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation t...

Geographic Factors and Health Disparities in Prostate Cancer

Socioeconomic and racial differences based on patient location may offer information on barriers to prostate cancer care. Cancer Control: Journal of the Moffitt Cancer Center

Prostate cancer symptoms aren't always obvious

(HealthDay)—Although about 1 in 7 men will be eventually be diagnosed with prostate cancer in his lifetime, the warning signs of the disease are often vague and may be confused with other conditions...

Prostate Cancer Pipeline H1 2017 Therapeutic Key Players 3-V Biosciences Inc, 4SC AG, Actinium ...

Prostate cancer is a form of cancer that affects men and starts off in the prostate gland. Prostate cancer usually occurs in older men. Symptoms Read more...

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for ...

Some Prostate Cancer Reflects Epigenetic Shift That Exposes Druggable Vulnerability

By studying molecular-level variations in prostate cancer, scientists hope to find ways to personalize prostate cancer treatments. One such variation has been highlighted by scientists based at Prince...

What men need to know: Prevention, diagnosis, and treatment of prostate cancer

Prostate cancer is the second leading cause of cancer death in men. Next to skin cancers, prostate cancer is the most common cancer diagnosed in American men.

WNT signalling in prostate cancer

WNT signalling pathway components are potentially important in prostate tumours, particularly in the development of castration-resistant prostate cancer and in the prostate tumour microenvironment. He...

Drugs and Medications [630 Associated Drugs and Medications listed on BioPortfolio]

Avodart [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Preferred Pharmaceuticals, Inc]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Doxazosin [Apotex Corp.]

DOXAZOSIN TABLETS, USP 1 mg, 2 mg, 4 mg and 8 mg

Doxazosin mesylate tablets 1 mg, 2 mg, 4 mg, 8 mg (doxazosin) [Genpharm Inc.]

DOXAZOSIN MESYLATE TABLETS 1 mg, 2 mg, 4 mg, 8 mg (doxazosin)

PubMed Articles [7541 Associated PubMed Articles listed on BioPortfolio]

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.

More than any other cancer, prostate cancer screening with the prostate-specific antigen (PSA) tests increases the risk a man will have to face a diagnosis of prostate cancer. The best evidence from s...

c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.

miR-493-5p downregulation has emerged as a critical player in cancer progression yet, the underlying mechanisms of miR-493-5p expression pattern and its function in prostate cancer remains to be eluci...

Influence of the neural microenvironment on prostate cancer.

Nerves are key factors in prostate cancer (PCa), but the functional role of innervation in prostate cancer is poorly understood. PCa induced neurogenesis and perineural invasion (PNI), are associated ...

The association between plasma C-peptide concentration and the risk of prostate cancer: a nested case-control study within a Japanese population-based prospective study.

The association between plasma C-peptide concentration and prostate cancer is unclear. Inconsistency of results from previous studies motivates this study. Using the Japan Public Health Center-based P...

Effect of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer.

Backgraoung and Objective: Prostate cancer is the most prevalent non-cutaneous cancer in men, which causes significant mortality among the patients. Since prostate cancer cells are stimulated by andro...

Clinical Trials [9496 Associated Clinical Trials listed on BioPortfolio]

Molecular Mechanisms Underlying Prostate Cancer Disparities

The purpose of this study is to further elucidate the molecular mechanisms underlying prostate cancer disparities. In previous work the investigators have identified a set of differential...

Quality of Life Study for Prostate Cancer Patients

Objectives: To measure and compare health-related quality of life after treatment or management for the modalities offered as primary therapy for prostate cancer at MD Anderson Cancer Cen...

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Single center, single-arm, open-label, 60-month follow-up phase IIb clinical trial. Men with localized prostate cancer will receive TOOKAD® Soluble VTP under general anesthesia. To evalu...

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

RATIONALE: Vitamin E supplements may stop or delay the development of prostate cancer in patients who are at risk of prostate cancer or who have prostate cancer. It is not yet known which ...

High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer

This is an Investigator Initiated, non-commercial, single center, non-randomized, single arm, open label pilot study on 194 patients. The patients are affected by prostate cancer but in tw...

Companies [3042 Associated Companies listed on BioPortfolio]

Chicago Prostate Cancer Center

Prostate Cancer Education Council

Prostate cancer remains the second-leading cause of cancer death in American men. More than 220,000 men will be diagnosed with prostate cancer this year and it is expected that 27,000 men will die fro...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

The Prostate Cancer Foundation

The Prostate Cancer Foundation is the world’s largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for pro...

Prostate Oncology Specialists, Inc.

According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United St...

More Information about "Chicago Prostate Cancer Center" on BioPortfolio

We have published hundreds of Chicago Prostate Cancer Center news stories on BioPortfolio along with dozens of Chicago Prostate Cancer Center Clinical Trials and PubMed Articles about Chicago Prostate Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chicago Prostate Cancer Center Companies in our database. You can also find out about relevant Chicago Prostate Cancer Center Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record